Apixaban Versus Warfarin in the Evaluation of Progression of Atherosclerotic Calcification and Vulnerable Plaque
Clinical trial NCT02090075 · COMPLETED
Trial details
- NCT number
- NCT02090075
- Sponsor
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2016-12-27
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.